Crossmark

Using proteomics to identify ubiquitin ligase–substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases

Crossref DOI link: https://doi.org/10.1007/s00018-019-03082-9

Published Online: 2019-03-27

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rayner, Stephanie L. https://orcid.org/0000-0003-1590-0071
Morsch, Marco https://orcid.org/0000-0001-9484-8050
Molloy, Mark P. https://orcid.org/0000-0003-4679-5868
Shi, Bingyang https://orcid.org/0000-0002-1043-3163
Chung, Roger https://orcid.org/0000-0002-9286-947X
Lee, Albert https://orcid.org/0000-0001-5156-0567
Funding

Funding for this research was provided by:

Cure for MND Foundation (GIA 1638)

National Health and Medical Research Council (APP1095215, APP1107644)

Motor Neurone Disease Research Institute of Australia (1628, 1715)
License Information

Text and Data Mining valid from 2019-03-27
More Information

Article History

Received: 16 January 2019

Revised: 14 March 2019

Accepted: 20 March 2019

First Online: 27 March 2019